Literature DB >> 26729040

Epidemiology: Lifetime risk of diabetes mellitus--how high?

Jaakko Tuomilehto1, Suhad Bahijri2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26729040     DOI: 10.1038/nrendo.2015.227

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study.

Authors:  Edward W Gregg; Xiaohui Zhuo; Yiling J Cheng; Ann L Albright; K M Venkat Narayan; Theodore J Thompson
Journal:  Lancet Diabetes Endocrinol       Date:  2014-08-12       Impact factor: 32.069

2.  A European evidence-based guideline for the prevention of type 2 diabetes.

Authors:  B Paulweber; P Valensi; J Lindström; N M Lalic; C J Greaves; M McKee; K Kissimova-Skarbek; S Liatis; E Cosson; J Szendroedi; K E Sheppard; K Charlesworth; A-M Felton; M Hall; A Rissanen; J Tuomilehto; P E Schwarz; M Roden; M Paulweber; A Stadlmayr; L Kedenko; N Katsilambros; K Makrilakis; Z Kamenov; P Evans; A Gilis-Januszewska; K Lalic; A Jotic; P Djordevic; V Dimitrijevic-Sreckovic; U Hühmer; B Kulzer; S Puhl; Y H Lee-Barkey; A AlKerwi; C Abraham; W Hardeman; T Acosta; M Adler; A AlKerwi; N Barengo; R Barengo; J M Boavida; K Charlesworth; V Christov; B Claussen; X Cos; E Cosson; S Deceukelier; V Dimitrijevic-Sreckovic; P Djordjevic; P Evans; A-M Felton; M Fischer; R Gabriel-Sanchez; A Gilis-Januszewska; M Goldfracht; J L Gomez; C J Greaves; M Hall; U Handke; H Hauner; J Herbst; N Hermanns; L Herrebrugh; C Huber; U Hühmer; J Huttunen; A Jotic; Z Kamenov; S Karadeniz; N Katsilambros; M Khalangot; K Kissimova-Skarbek; D Köhler; V Kopp; P Kronsbein; B Kulzer; D Kyne-Grzebalski; K Lalic; N Lalic; R Landgraf; Y H Lee-Barkey; S Liatis; J Lindström; K Makrilakis; C McIntosh; M McKee; A C Mesquita; D Misina; F Muylle; A Neumann; A C Paiva; P Pajunen; B Paulweber; M Peltonen; L Perrenoud; A Pfeiffer; A Pölönen; S Puhl; F Raposo; T Reinehr; A Rissanen; C Robinson; M Roden; U Rothe; T Saaristo; J Scholl; P E Schwarz; K E Sheppard; S Spiers; T Stemper; B Stratmann; J Szendroedi; Z Szybinski; T Tankova; V Telle-Hjellset; G Terry; D Tolks; F Toti; J Tuomilehto; A Undeutsch; C Valadas; P Valensi; D Velickiene; P Vermunt; R Weiss; J Wens; T Yilmaz
Journal:  Horm Metab Res       Date:  2010-04-13       Impact factor: 2.936

3.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

4.  Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).

Authors:  J Lindström; M Peltonen; J G Eriksson; P Ilanne-Parikka; S Aunola; S Keinänen-Kiukaanniemi; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  2012-10-24       Impact factor: 10.122

5.  The lifetime risk of developing breast cancer.

Authors:  E J Feuer; L M Wun; C C Boring; W D Flanders; M J Timmel; T Tong
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

6.  Lifetime risk and projected population prevalence of diabetes.

Authors:  D J Magliano; J E Shaw; S M Shortreed; W J Nusselder; D Liew; E L M Barr; P Z Zimmet; A Peeters
Journal:  Diabetologia       Date:  2008-09-23       Impact factor: 10.122

7.  Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.

Authors:  Symen Ligthart; Thijs T W van Herpt; Maarten J G Leening; Maryam Kavousi; Albert Hofman; Bruno H C Stricker; Mandy van Hoek; Eric J G Sijbrands; Oscar H Franco; Abbas Dehghan
Journal:  Lancet Diabetes Endocrinol       Date:  2015-11-11       Impact factor: 32.069

8.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

  8 in total
  1 in total

1.  Caffeine-inducible gene switches controlling experimental diabetes.

Authors:  Daniel Bojar; Leo Scheller; Ghislaine Charpin-El Hamri; Mingqi Xie; Martin Fussenegger
Journal:  Nat Commun       Date:  2018-06-19       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.